| Literature DB >> 27798163 |
Valentin Schatz1, Yannic Strüssmann1, Alexander Mahnke2, Gunnar Schley3, Maximilian Waldner4, Uwe Ritter5, Jens Wild1, Carsten Willam3, Nathalie Dehne6, Bernhard Brüne6, Jennifer M McNiff7, Oscar R Colegio7, Christian Bogdan2, Jonathan Jantsch8.
Abstract
Hypoxia-inducible factor-1α (HIF-1α), which accumulates in mammalian host organisms during infection, supports the defense against microbial pathogens. However, whether and to what extent HIF-1α expressed by myeloid cells contributes to the innate immune response against Leishmania major parasites is unknown. We observed that Leishmania-infected humans and L. major-infected C57BL/6 mice exhibited substantial amounts of HIF-1α in acute cutaneous lesions. In vitro, HIF-1α was required for leishmanicidal activity and high-level NO production by IFN-γ/LPS-activated macrophages. Mice deficient for HIF-1α in their myeloid cell compartment had a more severe clinical course of infection and increased parasite burden in the skin lesions compared with wild-type controls. These findings were paralleled by reduced expression of type 2 NO synthase by lesional CD11b+ cells. Together, these data illustrate that HIF-1α is required for optimal innate leishmanicidal immune responses and, thereby, contributes to the cure of cutaneous leishmaniasis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27798163 PMCID: PMC7249608 DOI: 10.4049/jimmunol.1601080
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422